| Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens DR Braxton, C Cohen, MT Siddiqui Diagnostic cytopathology 43 (4), 271-277, 2015 | 65 | 2015 |
| Digital PCR improves mutation analysis in pancreas fine needle aspiration biopsy specimens S Sho, CM Court, S Kim, DR Braxton, S Hou, VR Muthusamy, RR Watson, ... PLoS One 12 (1), e0170897, 2017 | 28 | 2017 |
| The GCTM‐5 Epitope Associated with the Mucin‐Like Glycoprotein FCGBP Marks Progenitor Cells in Tissues of Endodermal Origin LA Stamp, DR Braxton, J Wu, V Akopian, K Hasegawa, PT Chandrasoma, ... Stem Cells 30 (9), 1999-2009, 2012 | 28 | 2012 |
| Molecular and Cytogenomic Profiling of Hepatic Adenocarcinoma Expressing Inhibin, a Mimicker of Neuroendocrine Tumors: Proposal to Reclassify as “Cholangioblastic Variant of … DR Braxton, D Saxe, N Damjanov, K Stashek, S Shroff, JD Morrissette, ... Human Pathology, 2017 | 24 | 2017 |
| Case series and review of Ayurvedic medication induced liver injury CM Karousatos, JK Lee, DR Braxton, TL Fong BMC complementary medicine and therapies 21 (1), 1-11, 2021 | 23 | 2021 |
| Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution DR Braxton, R Zhang, JD Morrissette, A Loaiza‐Bonilla, EE Furth International Journal of Cancer, 2016 | 18 | 2016 |
| Molecular genomic profiling of adrenocortical cancers in clinical practice S Darabi, DR Braxton, BL Eisenberg, MJ Demeure Surgery, 2020 | 13 | 2020 |
| Predictive Biomarkers for Immunotherapy Response Beyond PD-1/PD-L1 S Darabi, DR Braxton, BL Eisenberg, MJ Demeure Oncology (Williston Park, NY) 34 (8), 321-327, 2020 | 11 | 2020 |
| Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett’s esophagus DR Braxton, DC Nickleach, Y Liu, AB Farris III Virchows Archiv 465 (2), 135-143, 2014 | 11 | 2014 |
| BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents S Darabi, DR Braxton, J Xiu, BA Carneiro, J Swensen, ES Antonarakis, ... Medicina 58 (12), 1818, 2022 | 10 | 2022 |
| Collagenous Gastritis in Primary Selective IgM Deficiency: Transition to EBV+ Gastric Adenocarcinoma T Narsai, H Su, D Braxton, S Gupta Case Reports in Immunology 2021, 2021 | 7 | 2021 |
| Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature TA Ault, DR Braxton, RA Watson, AO Marcus, TL Fong Journal of Medical Case Reports 17 (1), 1-6, 2023 | 6 | 2023 |
| ERBB family fusions are recurrent and actionable oncogenic targets across cancer types L Schubert, A Elliott, AT Le, A Estrada-Bernal, RC Doebele, E Lou, ... Frontiers in Oncology 13, 2023 | 6 | 2023 |
| An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma DC Madoff, N Abi-Jaoudeh, D Braxton, L Goyal, D Jain, BC Odisio, ... The Oncologist, 2022 | 5 | 2022 |
| Precision medicine, genetics and genomics in a community cancer clinic. S Darabi, DR Braxton, J Homer, C Weatherill, T Brodie, L Buchanan, ... Journal of Clinical Oncology 38 (15_suppl), e13511-e13511, 2020 | 5 | 2020 |
| Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions S Darabi, A Elliott, DR Braxton, J Zeng, K Hodges, K Poorman, J Swensen, ... Cancers 14 (6), 1505, 2022 | 4 | 2022 |
| Antibodies to a CA 19-9 related antigen complex identify SOX9 expressing progenitor cells in human foetal pancreas and pancreatic adenocarcinoma AM Farley, DR Braxton, J Li, K Trounson, S Sakar-Dey, B Nayer, T Ikeda, ... Scientific reports 9 (1), 1-15, 2019 | 4 | 2019 |
| Pathology molecular reflex testing improves turn-around-time and overall molecular testing rates in NSCLC. DR Braxton, Y Huang, S Darabi, F Chavez, PM Das, TJ Bowen Journal of Clinical Oncology 39 (15_suppl), e13507-e13507, 2021 | 3 | 2021 |
| HPV L1 in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16, HPV ISH, and Outcome DG Davis, DR Braxton, N Fatima, ST Momin, C Cynthia LABORATORY INVESTIGATION 94, 317A-317A, 2014 | 3* | 2014 |
| Programmatic Efforts Increase Adoption of Genomic Precision Medicine in Cancer Care in a Community Cancer Center S Darabi, D Braxton, J Homer, T Brodie, D Holnagel, B Eisenberg, ... JCO Precision Oncology 6, e2200090, 2022 | 2 | 2022 |
